INTRODUCTION
Snakebite envenomations continue to be a threat to public health in some parts of the world. At least 1,841,000 snakebites resulting in about 94,000 deaths are recorded annually (Chippaux et al., 1991; Pugh and Theakston, 1980) . In India alone, 35,000 to 50,000 die of snakebites annually (Morais and Massaldi, 2009 ). In Zimbabwe, about 270 cases of snakebites are recorded annually with a mortality rate of about 2% (Nhachi and Kasilo, 1994) , and a significant number of victims are not reported. Common poisonous snakes in Zimbabwe belong to four families; Colubrids (Boomslang), Vipers (Puff Adder), Elapids (Mambas and Cobras) and Atractaspids (Bibron Stilleto snake) (Muguti et al., 1994) .
Snake venom is a complex mixture containing several enzymes, peptides and non-protein components (Chippaux et al., 1991; Rucavado et al., 2004; Pithayanukul et al., 2009 ). The physiopathological effects of venom results from synergic action of the composite mixture (Currier et al., 2010) . The amount of snake venom component depends on the snake species, diet, season and geographical regions (Rodrgues et al., 1998; Currier et al., 2010) . Bitis arientans venom is mainly haemorrhagic and myotoxic which result from the proteinases and proteases action, mainly metalloproteinases and serine proteases. Haemorrhagic and proteases activity are the main cause of local tissue damage. In vitro assay using casein and fibrinogen are some of the methods used to measure haemorrhagic and proteolytic activities (Biondo et al., 2003) . The conventional antivenoms are expensive and do not combat local tissue damage except Batimastat. Although there are several snake venom components, proteinaases mainly cause local tissue damage which has been shown to be of medical importance. Anti-venom immunotherapy has been the only specific treatment against snake envenomations (Arce et al., 2003; Moraes et al., 2003; Gutiérrez et al., 1990) . However, there are various side effects of sera antivenoms such as bronchospasms, anaphylatic shock, serum sickness and pyrogen reaction (Lomente et al., 2008; Feofanov et al., 2005; Meenatchisundaram et al., 2009; Wong et al., 2010) . Moreover immunotherapy is relatively inefficient to neutral venom-induced local tissue damage (Gutiérrez et al., 2006; Gibbs and Mackessy, 2009) , and antivenoms are not always readily available in some regions of Africa and Asia (Chippaux et al., 1998; Rodrigues et al., 1998) . Therefore the search for novel venom inhibitors has expanded to include the possibility of using plants that may neutralize relevant toxins in the venoms and which may be readily available with minimum side effects (Mors et al., 2000; Borges et al., 2001; Biondo et al., 2003; Alam and Gomes, 2003; Januário et al., 2004; Oliveira et al., 2005) .
The use of medicinal plants play a significant role to cover the basic health needs not only in the developing countries, but also in developed countries (Selim et al., 2013) . Herbs have been a major source of drug formulations, for instance quinine and cough syrups, were developed from plants. Medicinal plants contain many compounds, such as polyphenols (phenolics), flavonoids, flavonols, alkaloids, saponnins and steroids which are among the other phytochemical compounds that have been shown to exhibit therapeutic activity, for example antivenom and anti-microbial properties (Mors et al., 2000; Dey and De, 2012; Selim et al., 2013; Barkatullah et al., 2013) . The mechanism of action varies from simple chelation of central metal ions, anti-oxidant scavenging to structural modification of the antigens (Mors et al., 2000) .
In some regions of Zimbabwe, venomous snakebites have been traditionally treated with infusions of herbs. However, a survey of literature shows that no studies are documented for the inhibitory activities of locally available plants. The aim of this study was to investigate the inhibitory effect of aqueous methanol crude root extracts of two locally available herbs traditionally used in treatment of snakebites, T. nobilis and V. zambesiaca, on the in vitro ability of B. arietans venom to breakdown casein (its caseinolytic effect). Determining the efficacy of extracts from these plants to neutralize the snake venom resources pave way to possible further studies on the development of anti-snake therapy from locally available resources.
MATERIALS AND METHODS
The two plants, T. nobilis and V. zambesiaca, were collected in Shamva, Northen Zimbabwe and identified at National Herbarium. The plant roots were dug, cleaned and carried to Bindura University Laboratory in previously cleaned polythene bags.
The plant root materials were air dried in a shed for eight weeks to ensure complete dryness (Meenatchisundaram et al., 2009; Biondo et al., 2003) . The plant root materials were ground into powder. The ground plant root materials were kept in previously cleaned capped-plastic containers (Alam and Gomes, 2003) . The B. arietans venom was donated by Snake World in Norton (Located about 15 km west of Harare). The venom was lyophilized and was stored at -20°C. When used in the analysis, the freeze-dried venom was dissolved in phosphate buffer saline (PBS) pH 7.4 to a required concentration. Casein, an analytical grade, was purchased from Sigma-Aldrich.
Determination of total phytochemicals in the root extracts

Flavonoids
A volume of 0.5 ml of 2% AlCl3-ethanol solution was added to 0.5 ml of plant extract. After one hour at room temperature, the absorbance was measured at 420 nm (Wolfe et al., 2003) . A yellow colour observed was an indication of the presence of flavonoids. The total flavonoids content was evaluated as mg/g quercetin equivalent and this was one-way obtained from the calibration curve (Kessler et al., 2003) .
Flavonols
A volume of 2 ml of plant extract was added to 2 ml of 2% of AlCl3-ethanol solution and 3 ml of 50 g/l sodium acetate solution. As described by Kumaran and Kumaran (2007) , the absorbance was measured at 440 nm after 2½ h at 20°C. The total flavonols were determined from the calibration curve and expressed as mg/g quercetin.
Phenolics
Total phenols were determined by the Folin-Ciocalteu reagent method (Kumaran and Karunakaran, 2007) . The plant extract (0.5 m of 1:10 g ml -1 ) or gallic acid (standard phenolic compound) was mixed with Folin-Ciocalteu reagent (5 ml, 1:10 diluted with distilled water) and aqueous sodium carbonate (4 ml, 1 M). The mixtures were allowed to stand for 15 min and the total phenols were determined spectrophotometrically at 765 nm as described by Adedago et al. (2008) .
Caseinolytic and anti-caseinolytic activity
A 200 ml casein stock solution of concentration 0.59 g/ml was prepared using the method by Kunitz (1947) and diluted to 1% working solution. A volume of 0.5 ml of crude venom of concentration 0.56 µg/ml in phosphate buffer saline pH 7.4 was added to 1 ml of 1% casein. The stock solution was divided into aliquots of 4 ml each. A set of 40 test tubes containing same concentrations were incubated at 37 °C. The caseinolytic activity was determined by spectrophotometric scanning of the composite mixture of one test tube after the other, at 1 min intervals. Therefore, one test tube was representing a 1 min change in the concentration of casein as a result of the venom action. A set of control experiments with the inhibitor and/or solvents (buffer/ethanol) were performed simultaneously. The percent of inhibition was calculated as:
Where Amax is the absorbance of casein not exposed to venom, Amin is the absorbance of casein exposed to venom plus an equal volume of buffer, and Asum is the absorbance of casein exposed to venom plus an equal volume of sample containing inhibitor (Girish and Kemparaju, 2005) . In each case, the test-tubes were incubated at 37°C and scanned after every 1 min using a Shimadzu UV1601 spectrophotometer.
RESULTS
The absorbance of casein shown is shown in Figure 1 . Casein was found to be absorbed at 288.5 nm using a Shimadzu UV1601 Spectrophotometer. Caseinolytic activity was examined at this wavelength. Figure 2 shows caseinolytic activity of the venom of B. arietans. It can be observed that increasing the venom concentration results in an increase in the rate of caseinolytic acitivity. The graph helps to determine the minimum venom concentration that brings about a 50% (LD 50 ) and 100% (LD 100 ) caseinolytic activity. Figures 3 and 4 showed that the kinetics followed a first-order mechanism. Inhibition activity ( Figure 5 ) of the crude plant extracts was correlated to total flavonoid, flavonol and phenolic content in T. nobilis and V. Zambesiaca, and the linear regression parameters are shown in Table 1 .
DISCUSSION
From in vitro tests, caseinolytic activity was determined as the ratio of the absorbance of casein relative to the absorbance of the venom-casein mixture. Figures 1 and  2 show the spectrum of casein and the variation of the caseinolytic effect with venom concentration, respectively. The minimum venom dose that resulted in 100% caseinolytic activity was determined to be 0.56 µg/ml. Plots used to obtain kinetic parameters are shown in Figures 3 and 4 , and these were obtained using the Lineweaver- , respectively. These results tend to suggest that the digestion of casein by B. arietans venom was characterised by fast reaction kinetics.
Caseinolytic activity induced by the crude B. arietans venom was inhibited when the venom was incubated with T. nobilis and V. zambesiaca root extracts at different concentrations ( Figure 5) . When compared to the inhibitory effect of quercetin as a typical bioactive flavonoid, the plant extracts exhibited a greater inhibitory effect on the action of the snake venom. Incubating the venom-casein mixture after a dosage of 10.5 µg/ml quercetin resulted in a 50% inhibition, whereas a 70 and 60% inhibition were observed for a 6.25 and 8.50 µg/ml dosage with T. nobilis and V. zambesiaca extracts, respectively.
The total flavonoid, flavonol and phenolic content of the herbs were higher in T. nobilis than in V. zambesiaca, as shown in Table 1 . These findings tend to suggest that the higher inhibitory effect observed for T. nobilis could be explained in terms of the presence of higher levels of bioactive compounds. The mechanisms of action of flavonols, flavonoids and phenolic compounds are through scavenging or chelating process (Girish and Kemparaju, 2005) . Such compounds participate in the chelation of the metal atom (zinc) present at the catalytic center of metalloproteinases. Components of the plant extract may occupy sites in the venom, preventing binding of the substrate to the enzymes, and this may take place through covalent or non-covalent bonding (Biondo et al., 2003) . However, it suffices to mention that there is still a greater possibility of other bioactive compounds not quantified in this study playing a significant role in the inhibition process.
Substances identified in plants reputed to neutralize the effects of snake venoms, spanning a wide range of molecules, include phenolics, hydroxybenzoic acids, cinnamic acid derivatives, curcuminoids, flavonoids, and tannis, among others (Mors et al., 2000) . Additional work to characterise the active phytochemical compounds including those classified under flavonoids, flavonols and phenolics present in T. nobilis than in V. zambesiaca is underway in our laboratories and will be reported in due course.
Statistical analysis
Results are expressed as mean ± standard deviation obtained from triplicates run on three independent analyses. Correlation between the inhibition and total phenolics, flavonoids and flavonols was obtained by using analysis of variance (ANOVA) at 99% confidence interval.
Conclusion
The aqueous methanol crude extracts of T. nobilis and V. zambesiaca demonstrated significant abilities to inhibit the caseinolytic effect of crude B. arietans venom under in vitro conditions. A study of some compounds correlated with inhibition of crude venoms showed that the higher inhibitory effect observed for T. nobilis could be related to the higher composition of flavonoids, flavonols and phenolics. This study therefore provides useful initial findings which can be exploited in the continued search for effective therapy on the local effects of snakebites.
